Results 31 to 40 of about 10,275,652 (198)
Stage II Seminoma: Why Chemotherapy Should Remain a Standard
Chemotherapy (three cycles of bleomycin + etoposide + cisplatin or four of etoposide + cisplatin) cures the vast majority of stage II seminomas. Retroperitoneal lymph node dissection (RPLND) is safe in early-stage seminoma, but the risk of relapse is not
Natacha Naoun +2 more
doaj +1 more source
Stage II: Ranking of lectures.
Stage II: Ranking of lectures.
Mary E. Wood (4248898) +5 more
core +1 more source
Risk factors for postoperative recurrence in patients with stage II colorectal cancer
Background Recurrences are the main reasons for unfavorable outcomes for patients with stage II colorectal cancer (CRC). To obtain a clear understanding of the high-risk factors, further investigation is warranted.
Zhi-Zhong Xiong +7 more
doaj +1 more source
Musicie być mocni! : drogowskazy Jana Pawła II dla niepełnosprawnych [PDF]
Biblioteka Instytutu Jana Pawła II w Wałbrzychu ;
Jan Paweł II (papież ; 1920-2005)
core
Centrality analysis of stage-II network.
Centrality analysis of stage-II network.
Ashok Palaniappan (3165975) +2 more
core +1 more source
Moduland decomposition of stage-II network.
Moduland decomposition of stage-II network.
Ashok Palaniappan (3165975) +2 more
core +1 more source
Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer
Background Although evaluation of at least 12 lymph nodes (LNs) is recommended as the minimum number of nodes required for accurate staging of colon cancer patients, there is disagreement on what constitutes an adequate identification of such LNs ...
Bumpers Harvey L +10 more
doaj +1 more source
Treatment Options in Early Stage (Stage I and II) of Oropharyngeal Cancer: A Narrative Review
Objective: to show an overview on the treatments’ options for stage I and II oropharyngeal carcinomasquamous cell carcinoma (OPSCC). Background: The traditional primary treatment modality of OPSCC at early stages is intensity modulated radiation therapy (
Giuseppe Meccariello +6 more
doaj +1 more source
GO enrichment analysis of Stage-II network.
GO enrichment analysis of Stage-II network.
Ashok Palaniappan (3165975) +2 more
core +1 more source
Mutational load comparison between stage II patients groups.
Mutational load comparison between stage II patients groups.
Javier Rasero (4591531) +13 more
core +1 more source

